Diuretics in pediatrics
- PMID: 36595088
- DOI: 10.1007/s00431-022-04768-2
Diuretics in pediatrics
Abstract
Diuretics are frequently prescribed drugs and help managing several pathological conditions, including acute and chronic kidney disease, nephrotic syndrome, congestive heart failure, ascites, systemic and pulmonary hypertension. Diuretic classes include among others osmotic diuretics and carboanhydrase inhibitors, loop diuretics, thiazides, and potassium-sparing diuretics. In this educational article, we aim at reviewing indications, mechanisms of action, and side effects, as well as basic pharmacokinetics considerations and data on diuretics in children, supporting practicing clinicians in choosing (and understanding the background of) the best-suited diuretic regimen for the individual patient. Newer diuretic classes like vaptans and sodium glucose type 2 cotransporter inhibitors, the recent controversies on hydrochlorothiazide, and the issue of diuretic resistance, will also be briefly addressed.
Conclusion: This educational review offers a didactical overview of diuretics in Pediatrics.
What is known: • Diuretics are frequently prescribed drugs in both adults and children. • They increase water and sodium excretion, reducing fluid overload.
What is new: • This article reviews indications, mechanisms of action, side effects, and basic pharmacokinetics facts on diuretics in Paediatrics. • It also addresses current issues, like the management of diuretic resistance, the recent controversy on hydrochlorothiazide, and the novel classes vaptans and gliflozins.
Keywords: Child; Diuretic; Fluid overload; Furosemide; Hydrochlorothiazide; Spironolactone.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Ellison DH (2019) Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 14(8):1248–1257. https://doi.org/10.2215/CJN.09630818 - DOI - PubMed - PMC
-
- van der Vorst MM, Kist JE, van der Heijden AJ, Burggraaf J (2006) Diuretics in pediatrics : current knowledge and future prospects. Paediatr Drugs 8(4):245–264. https://doi.org/10.2165/00148581-200608040-00004 - DOI - PubMed
-
- Guignard JP, Iacobelli S (2021) Use of diuretics in the neonatal period. Pediatr Nephrol 36(9):2687–2695. https://doi.org/10.1007/s00467-021-04921-3 - DOI - PubMed
-
- Heymann WR (2019) The expanding saga of hydrochlorothiazide and skin cancer. J Am Acad Dermatol 80(2):380–381. https://doi.org/10.1016/j.jaad.2018.12.006 - DOI - PubMed
-
- Piffer A, Bianchetti MG, Leoni-Foglia C, Simonetti GD, Milani GP, Lava SAG (2022) Vaptans for oedematous and hyponatraemic disorders in childhood: a systematic literature review. Br J Clin Pharmacol 88(10):4474–4480. https://doi.org/10.1111/bcp.15367 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
